JSM Activity #129

This is the preliminary program for the 2003 Joint Statistical Meetings in San Francisco, California. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 2-5, 2003); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2003 Program page
Legend: = Applied Session, = Theme Session, = Presenter
Hotels: H = Hilton San Francisco, R = Reniassance Parc Hotel 55, N = Nikko San Francisco
Add To My Program
129 Applied Session Mon, 8/4/03, 10:30 AM - 12:20 PM H-Mason Room A/B
ROC Analysis, Diagnostic Tests, and Agreement - Contributed - Papers
Biometrics Section
Chair(s): Wenyaw Chan, University of Texas, Houston
     10:35 AM   Nonparametric Regression for ROC analysis — E. S. Venkatraman, Memorial Sloan-Kettering Cancer Center
     10:50 AM   Small Sample Performance of GEE-Ordinal Regression Estimators of ROC Curves — Alicia Y. Toledano, Brown University
     11:05 AM   A Cautionary Note on the Robustness of Latent Class Models for Estimating Diagnostic Error without a Gold Standard — Paul S. Albert, National Cancer Institute; Lori E. Dodd, National Cancer Institute
     11:20 AM   Estimating Diagnostic Test Parameters from Longitudinal Data without a Gold Standard — Huiyan Zhao, Iowa State University; Michael J. Daniels, University of Florida
     11:35 AM   Mixed-effects Models to Assess Consistency and Reliability Across Multiple Evaluations — Tzu-Cheg Kao, Uniformed Services University of the Health Sciences; Yvonne Sparling; James Rochon, Duke Clinical Research Institute
     11:50 AM   A Discussion of Clinical Outcome Assessment Development — Jingyu Liu, Allergan Pharmaceuticals; Catherine Turkel, Allergan Pharmaceuticals; Thomas Lin, Allergan Pharmaceuticals
     12:05 PM   Floor Discussion
 

JSM 2003 For information, contact meetings@amstat.org or phone (703) 684-1221. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2003